Picture of Optimind Pharma logo

OMND Optimind Pharma Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Optimind Pharma, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2023
February 28th
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
fx
Final
fx
Final
Final
Cash
Cash and Equivalents
Cash and Short Term Investments0.0570.010.0070.0010.552
Net Total Accounts Receivable
Net Total Receivables0.116
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.0680.0110.0110.0220.668
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.095
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets0.0680.0110.0110.0221.35
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1.141.060.0880.1880.625
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities1.141.060.0880.1880.715
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity-1.08-1.05-0.077-0.1660.64
Total Liabilities & Shareholders' Equity0.0680.0110.0110.0221.35
Total Common Shares Outstanding